Jessica Ellsworth, an attorney at Hogan Lovells who represented the drug manufacturer that makes the brand name version of mifepristone, said the decision "preserves crucial access to a drug relied on by millions of patients." The order, she said, "provides continuity to all concerned as we litigate the underlying issues in this case."
Thomas and Alito said they would have denied the Biden administration's request and allowed the restrictions on the drug to take effect.
Send an email
